Noemie Jourde-Chiche
Overview
Explore the profile of Noemie Jourde-Chiche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
2462
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jourde-Chiche N, Augusto J, Faguer S
Nephrol Ther
. 2025 Feb;
20(7):666-673.
PMID: 39917792
Renal involvement in ANCA vasculitides (AAV) is frequent and often severe, leading to end-stage kidney disease either immediately, in the follow-up or after episodes of relapses. Renal involvement is associated...
2.
Bobot M, Guedj E, Resseguier N, Faraut J, Garrigue P, Nail V, et al.
Kidney Int Rep
. 2024 Oct;
9(10):2988-2995.
PMID: 39430169
Introduction: Chronic kidney disease (CKD) is associated with an increased risk of cognitive impairment. This cognitive impairment is associated with an increased permeability of blood-brain barrier (BBB) in rodents with...
3.
Sallee M, Resseguier N, Crepin T, Bertin D, Bertrand D, Bobot M, et al.
Kidney Int Rep
. 2024 Sep;
9(9):2767-2773.
PMID: 39291196
Introduction: Apheresis allows the fast removal of autoantibodies in anti-glomerular basement membrane (anti-GBM) disease, and in severe antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. The CINEVAS study tested whether immunoadsorption (IA) allowed...
4.
Amoura Z, Bader-Meunier B, Antignac M, Bardin N, Belizna C, Belot A, et al.
Rev Med Interne
. 2024 Aug;
45(9):559-599.
PMID: 39191627
Because Systemic Lupus Erythematosus (SLE) is a rare disease, and due to the significant prognostic impact of early management, a diagnosis confirmed by a physician with experience in SLE is...
5.
Lafargue M, Duong van Huyen J, Rennke H, Essig M, Bobot M, Jourde-Chiche N, et al.
Clin Kidney J
. 2024 Aug;
17(8):sfae185.
PMID: 39099564
Introduction: The objective of this study was to describe kidney involvement in patients with myelodysplastic syndromes (MDS), their treatments, and outcomes. Methods: We conducted a multicenter retrospective study in seven...
6.
Himbert M, Jourde-Chiche N, Chapart L, Charles N, Baumstarck K, Daugas E
RMD Open
. 2024 Jun;
10(2).
PMID: 38942591
Objectives: Discontinuation or continuation of maintenance immunosuppressive therapy (MIST) after a severe lupus nephritis (LN) requires measuring the risk of relapse but reliable clinical and biological markers are lacking. The...
7.
Bobot M, Heim X, Max H, Boucraut J, Simeone P, Stein C, et al.
Kidney Int Rep
. 2024 Jun;
9(6):1641-1653.
PMID: 38899195
Introduction: During COVID-19, renal impairment is associated with poor prognosis in intensive care unit (ICU). We aimed to assess the existence and incidence of early renal dysfunction and its prognostic...
8.
Bettacchioli E, Chiche L, Chaussabel D, Cornec D, Jourde-Chiche N, Rinchai D
Database (Oxford)
. 2024 May;
2024.
PMID: 38805754
In the field of complex autoimmune diseases such as systemic lupus erythematosus (SLE), systems immunology approaches have proven invaluable in translational research settings. Large-scale datasets of transcriptome profiling have been...
9.
Destere A, Teisseyre M, Merino D, Cremoni M, Gerard A, Crepin T, et al.
Kidney Int Rep
. 2024 Feb;
9(1):134-144.
PMID: 38312797
Introduction: Rituximab is a first-line treatment for membranous nephropathy. Nephrotic syndrome limits rituximab exposure due to urinary drug loss. Rituximab underdosing (serum level <2 μg/ml at month-3) is a risk...
10.
Jourde-Chiche N, Chiche L
Lancet Rheumatol
. 2024 Feb;
6(3):e133-e134.
PMID: 38301681
No abstract available.